Missing/wrong data?
Log in to edit
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
scientific article
Author/s
author: Michael Gnant, Gunter von Minckwitz, Arlene Chan, Marc Buyse, Suzette Delaloge, Bent Ejlertsen, Norikazu Masuda, Hiroji Iwata, Beverly Moy, Vernon Harvey
Work details
Publication date
March 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.